Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 1,094 descriptions
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M-M-RVAXPRO | [3] Measles virus vaccine live attenuated Measles virus vaccine live attenuated,Mumps virus strain B level jeryl lynn live antigen, Rubella virus vaccine [3] Measles virus vaccine live attenuated, Mumps virus strain B level jeryl lynn live antigen, Rubella ... | - | - | - | [1] 107 107 💬1. M-M-RVAXPRO
| ||||||||||||
2 | M071754 | - | - | - | - | [1] 145 145 💬2. M071754
| ||||||||||||
3 | M2591 25 mg QD | - | - | - | - | [1] 46 46 💬3. M2591 25 mg QD
| ||||||||||||
4 | M281 | - | - | - | - | [5] 11 11, 46, 49, 53, 61 💬
| ||||||||||||
5 | M281 Injection | - | - | - | - | [1] 11 11 💬5. M281 Injection
| ||||||||||||
6 | M2951 | - | - | - | - | [3] 13 13, 46, 49 💬
| ||||||||||||
7 | M2951 (Other Name: Evobrutinib) | [1] Evobrutinib Evobrutinib | [1] Evobrutinib
Evobrutinib
💬7. M2951 (Other Name: Evobrutinib)
| [1] BTK BTK 💬7. M2951 (Other Name: Evobrutinib)
| [7] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 [7] B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway ... | [1] 49 49 💬7. M2951 (Other Name: Evobrutinib)
| ||||||||||||
8 | M2951 50 mg BID | - | - | - | - | [1] 46 46 💬8. M2951 50 mg BID
| ||||||||||||
9 | M2951 75 mg QD | - | - | - | - | [1] 46 46 💬9. M2951 75 mg QD
| ||||||||||||
10 | M5049 | - | - | - | - | [1] 49 49 💬10. M5049
|